A recent study showed that the inhibition of miR-19a in a mouse asthma model attenuated inflammation and mucus production induced by Th1 cells, suppressed the Th2 inflammatory response, and repressed dendritic cell maturation by increasing RUNX3 [99]. This evidence concerns the gene RUNX3 and asthma.